Fig. 1

SLC38A2 is overexpressed and predicts poor prognosis of patients in GC. (A) The mRNA expression level of various SLC39A family members between tumor and normal tissues in GC (*P < 0.05, **P < 0.01). (B) The prognostic value of SLC38A2 and SLC38A4 in GC patients (HR: hazard ratio). (C) Representative IHC staining images of SLC39A2 expression in normal, well and poorly differentiated cancer tissues. (D) SLC38A2 expression level in GC tumor tissues and corresponding normal tissues (*P < 0.05); (E) SLC38A2 expression level in human gastric mucosal cells (GES1) and GC cell lines (*P < 0.05, **P < 0.01, ***P < 0.001)